brilliant rns imo22 Aug 2017 10:23
1. Access to the US, the worlds largest probiotic market, with an estimated retail value of $7.1 billion per annum
2. Extension of LPLDL® into dairy applications utilising Sacco's network in the dairy industry to develop commercial opportunities identified by them in the global $35.5 billion probiotic dairy market
3. Economies of scale, significantly reducing the manufacturing cost of LPLDL®, increasing OptiBiotix's profitability, and opening up new application opportunities
4. Long-term security of supply with Sacco's ability to produce at different locations from multiple facilities
5. A commitment from Sacco to support the funding of further developments of LPLDL®, including marketing and human studies, to expand the commercialisation of LPLDL® into new markets